​Mankind Pharma on Wednesday reported a 56% year-on-year (YoY) jump in net profit to Rs 460 crore in Q3FY24 led by strong domestic formulation sales and one-off US export opportunities.
Subscribe To Our Free Newsletter |
​Mankind Pharma on Wednesday reported a 56% year-on-year (YoY) jump in net profit to Rs 460 crore in Q3FY24 led by strong domestic formulation sales and one-off US export opportunities.
Subscribe To Our Free Newsletter |
EvoLve theme by Theme4Press • Powered by WordPress & Rakesh Jhunjhunwala Latest Stock Market News
The Most Valuable Commodity Is Information!